Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Oct;83(10):1183-5.
doi: 10.1136/bjo.83.10.1183.

Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid

Affiliations
Clinical Trial

Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid

O Cekiç et al. Br J Ophthalmol. 1999 Oct.

Abstract

Aims: To assess the subretinal fluid (SRF) levels of ofloxacin following topical, oral or combined administration.

Methods: 31 patients undergoing conventional retinal reattachment surgery were randomly assigned to three groups. Nine patients received topical ofloxacin, 11 patients received oral ofloxacin, and the other 11 patients received combined administration. Collected SRF samples were analysed for drug level by using high performance liquid chromatography.

Results: SRF drug levels after oral and combined administration were significantly higher than that after topical administration (p=0.0002 and p=0.0002, respectively) while there was no significant difference between oral and combined administration (p=0.0844).

Conclusions: Ocular bioavailability of ofloxacin in SRF after oral and combined administration is equivalent. The addition of oral ofloxacin to topical therapy increased drug SRF penetration sixfold.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of subretinal fluid levels of ofloxacin obtained after different modes of administration.

Similar articles

Cited by

References

    1. Br J Ophthalmol. 1992 Dec;76(12):714-8 - PubMed
    1. Drugs. 1991 Nov;42(5):825-76 - PubMed
    1. Br J Ophthalmol. 1994 Jul;78(7):577-80 - PubMed
    1. Antimicrob Agents Chemother. 1995 Feb;39(2):549-52 - PubMed
    1. Br J Ophthalmol. 1995 Jun;79(6):606-9 - PubMed

Publication types